AACR 2022 | Booth #2210
April 8-13, 2022
Advancing cancer and immunotherapy research with immunosequencing
The American Association for Cancer Research (AACR) Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy.
Adaptive is excited to be hosting a special symposium during the event, where we will be highlighting exciting research taking place across the cancer research landscape and how immune repertoire profiling with the immunoSEQ Technology is uniquely suited to answer questions related to immuno-oncology. If you are attending AACR in-person, we hope you’ll stop by booth #2210 and connect.
Exhibitor Spotlight Theater
Utilizing immunosequencing to study oncology targets and therapies
Monday, April 11 | 12:30-1:30pm
Theater B, Exhibit Hall, Ernest N. Morial Convention Center
Join us to learn about:
- The principles behind the immunoSEQ Technology and an overview of the immunoSEQ HLA Classifier
- Immuno-oncology target identification using coupled immunogenomics
- Transgenic T-cell receptor adoptive cell therapies: addressing epigenetic suppression & optimizing therapies with immunosequencing
Patrick Raber, Ph.D.
Director, Business Development
Kellie N. Smith, Ph.D.
Assistant Professor of Oncology
Bloomberg~Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine
Theodore Scott Nowicki, MD, Ph.D.
Assistant Professor-in-Residence, Pediatric Hematology/Oncology
University of California Los Angeles
Have Questions? Need to speak with someone?
Learn how immunoSEQ® T-MAP™ COVID can help uncover the T-cell immune response in COVID-19.Learn More
Looking for more information? Help with experimental design or technical support? Interested in speaking to someone?Contact Us
Access technical documents for getting started with the immunoSEQ® Service product, grant writing support, and FAQs.Learn More